Risk Factors and Prognosis of Nosocomial Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Escherichia coli
Year: 2010
Type: article
Study design: Observational Study
Abstract: Extended-spectrum-beta-lactamase (ESBL)-producing Escherichia coli (ESBLEC) is an increasing cause of community and nosocomial infections worldwide. However, there is scarce clinical information about nosocomial bloodstream infections (BSIs) caused by these pathogens. We performed a study to investigate the risk factors for and prognosis of nosocomial BSIs due to ESBLEC in 13 Spanish hospitals. Risk factors were assessed by using a case-control-control study; 96 cases (2 to 16% of all nosocomial BSIs due to E. coli in the participating centers) were included; the most frequent ESBL was CTX-M-14 (48% of the isolates). We found CTX-M-15 in 10% of the isolates, which means that this enzyme is emerging as a cause of invasive infections in Spain. By repetitive extragenic palindromic sequence-PCR, most isolates were found to be clonally unrelated. By multivariate analysis, the risk factors for nosocomial BSIs due to ESBLEC were found to be organ transplant (odds ratio [OR]=4.8; 95% confidence interval [CI]=1.4 to 15.7), the previous use of oxyimino-beta-lactams (OR=6.0; 95% CI=3.0 to 11.8), and unknown BSI source (protective; OR=0.4; 95% CI=0.2 to 0.9), and duration of hospital stay (OR=1.02; 95% CI=1.00 to 1.03). The variables independently associated with mortality were a Pitt score of >1 (OR=3.9; 95% CI=1.2 to 12.9), a high-risk source (OR=5.5; 95% CI=1.4 to 21.9), and resistance to more than three antibiotics, apart from penicillins and cephalosporins (OR=6.5; 95% CI=1.4 to 30.0). Inappropriate empirical therapy was not associated with mortality. We conclude that ESBLEC is an important cause of nosocomial BSIs. The previous use of oxyimino-beta-lactams was the only modifiable risk factor found. Resistance to drugs other than penicillins and cephalosporins was associated with increased mortality.
Source: Journal of Clinical Microbiology
DOI: 10.1128/jcm.02353-09
Authors: Jesús Rodríguez-Baño, Encarnación Picón, Paloma Gijón, José Ramón Hernández, Jose M. Cisneros, Carmen Peña, Manuel Almela, Benito Almirante, Fabio Grill, Javier Colomina, Sonia Molinos, Antonio Oliver, Carlos Fernández-Mazarrasa, Gemma Navarro, Ana Coloma, Lorena López-Cerero, Alvaro Pascual
Institutions: Hospital Universitario Virgen Macarena, Universidad de Sevilla, Hospital General Universitario Gregorio Marañón, Hospital Universitario Virgen del Rocío, Bellvitge University Hospital, Hospital Clínic de Barcelona, Vall d'Hebron Hospital Universitari, Hospital Universitario Ramón y Cajal, Hospital de La Ribera, Hospital Universitari Germans Trias i Pujol, Hospital Universitario Son Dureta, Marqués de Valdecilla University Hospital, Corporació Sanitària Parc Taulí, Hospital de Sant Pau
Language: English
Subfield: Microbiology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: nosocomial bloodstream infection, extended-spectrum beta-lactamase, ESBL-producing Escherichia coli, CTX-M-14, CTX-M-15, risk factors, mortality, organ transplant recipients, antibiotic resistance, empirical antibiotic therapy, clonal relatedness, RAPD-PCR, Pitt score, length of hospital stay
Open Access status: green
Award: G1123387284
OpenAlex ID: W2163100965
